February 12, 2020 February 12, 2020Categories Trial ResultsTrial Results: New TAILORx data shows chemotherapy benefit for women at high risk of breast cancer recurrenceThe TAILORx trial answers questions about when to use chemotherapy to treat the most common type of breast cancer.
October 14, 2019 October 14, 2019Categories Trial ResultsTrial Results: With E1912, there is a new standard of care for the initial treatment of patients with chronic lymphocytic leukemiaThe combination of ibrutinib plus rituximab was superior to standard treatment for CLL patients age 70 and younger.
